Finance

Beta
Lists
PMCB:NASDAQ
Pharmacyte Biotech Inc
$0.79
+2.94%
(+0.023) 1D
May 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMCB...
Open
$0.78
High
$0.83
Low
$0.77
Mkt. cap
8.46M
Avg. vol.
227.25K
Volume
237.56K
52-wk high
$1.51
52-wk low
$0.63
EPS
-$1.05
Beta
0.46
Shares outstanding
10.74M
No. of employees
2
News stories
From sources across the web
About Pharmacyte Biotech Inc
CEO-
Employees2
Founded1996
HeadquartersLas Vegas, Maryland, United States
SectorBiotechnology
Websitepharmacyte.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
126.73K
95.16K
141.08K
93.11K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
915.13K
753.15K
1.23M
2.02M
Operating expense
1.04M
848.30K
1.38M
2.12M
Total operating expenses
1.04M
848.30K
1.38M
2.12M
Operating income
-1.04M
-848.30K
-1.38M
-2.12M
Other non operating income
-242.80K
-4.79M
-5.91M
1.04M
EBT including unusual items
11.75M
-8.36M
-7.42M
746.86K
EBT excluding unusual items
-1.05M
-5.42M
-7.08M
-849.20K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
11.75M
-8.36M
-7.42M
746.86K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
229.88K
217.79K
206.39K
230.67K
Interest expense
-
-
-
-
Net interest expenses
229.88K
217.79K
206.39K
230.67K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer